CHU de Clermont-Ferrand
CHU de Clermont-Ferrand
Clermont-Ferrand, France5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of an Early and Extended Rehabilitation Program Combining Individually Tailored Nutrition and Physical Activities on Patient Outcomes After Invasive Mechanical Ventilation and Vasopressor Therapy in the ICU | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock | Recruiting | Not applicable | 2026-10-02 | NCT06581939 | |
| Polyspecific Antibodies in Lymphoproliferative T-cell Disorders | Peripheral T Cells Lymphoma (PTCL) | Recruiting | Phase 1 / Phase 2 | 2026-08-20 | NCT06495723 | |
| Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE) | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, bacterial infectious disease, connective tissue disorder, gram-positive bacterial infections, muscle tissue disorder, musculoskeletal system disorder, polymyalgia rheumatica, rheumatic disorder, rheumatic fever, streptococcal infection | Not yet recruiting | Not stated | 2026-06-08 | NCT07132164 | |
| AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Hemorrhage, Myeloproliferative Disorders, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, acquired polycythemia vera, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, cardiovascular disorder, cellular phase chronic idiopathic myelofibrosis, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, neoplasm, primary myelofibrosis, thrombocytosis disease, vascular disorder, venous thromboembolism | Recruiting | Phase 3 | 2026-03-20 | NCT05198960 | |
| Zimmer POLAR Persona - TKA (EMEA Study) | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, polyarticular arthritis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2025-11-25 | NCT02337244 |